Literature DB >> 26424946

Synthetic cannabinoids and acute kidney injury.

Weeraporn Srisung1, Faisal Jamal1, Sharma Prabhakar1.   

Abstract

Synthetic cannabinoids (SCB) are a family of chemicals that bind to cannabinoid receptors and cause psychoactive effects. Over the past few years, they have been increasingly used for recreational purposes, especially by young adults, and have been reported to have many adverse effects. Acute kidney injury (AKI) has been recently reported; the pathophysiology of SCB-induced AKI is unknown. We report three cases of AKI in the setting of SCB use. The peak serum creatinine levels ranged from 3.0 to 5.7 mg/dL; one patient required hemodialysis. SCB can induce AKI.

Entities:  

Year:  2015        PMID: 26424946      PMCID: PMC4569229          DOI: 10.1080/08998280.2015.11929313

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  9 in total

1.  Diabetic nephropathy: do cannabinoids contribute?

Authors:  Leon A Bach
Journal:  Endocrinology       Date:  2012-03       Impact factor: 4.736

Review 2.  Clinical inquiries. How much can exercise raise creatine kinase level--and does it matter?

Authors:  Joshua Latham; Darren Campbell; William Nichols; Tim Mott
Journal:  J Fam Pract       Date:  2008-08       Impact factor: 0.493

3.  First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometry.

Authors:  Ariane Wohlfarth; Shaokun Pang; Mingshe Zhu; Adarsh S Gandhi; Karl B Scheidweiler; Hua-fen Liu; Marilyn A Huestis
Journal:  Clin Chem       Date:  2013-09-06       Impact factor: 8.327

4.  Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db mice.

Authors:  D H Nam; M H Lee; J E Kim; H K Song; Y S Kang; J E Lee; H W Kim; J J Cha; Y Y Hyun; S H Kim; S Y Han; K H Han; J Y Han; Dae Ryong Cha
Journal:  Endocrinology       Date:  2012-01-10       Impact factor: 4.736

Review 5.  Cannabimimetic indoles, pyrroles and indenes.

Authors:  J W Huffman
Journal:  Curr Med Chem       Date:  1999-08       Impact factor: 4.530

Review 6.  Drug-induced nephrotoxicity.

Authors:  Cynthia A Naughton
Journal:  Am Fam Physician       Date:  2008-09-15       Impact factor: 3.292

7.  AKI associated with synthetic cannabinoids: a case series.

Authors:  Gautam Kantilal Bhanushali; Gaurav Jain; Huma Fatima; Leah J Leisch; Denyse Thornley-Brown
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-14       Impact factor: 8.237

8.  Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats.

Authors:  P Janiak; B Poirier; J-P Bidouard; C Cadrouvele; F Pierre; L Gouraud; I Barbosa; J Dedio; J-P Maffrand; G Le Fur; S O'Connor; J-M Herbert
Journal:  Kidney Int       Date:  2007-09-19       Impact factor: 10.612

9.  Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.

Authors:  Federica Barutta; Alessandro Corbelli; Raffaella Mastrocola; Roberto Gambino; Vincenzo Di Marzo; Silvia Pinach; Maria Pia Rastaldi; Paolo Cavallo Perin; Gabriella Gruden
Journal:  Diabetes       Date:  2010-01-12       Impact factor: 9.461

  9 in total
  8 in total

1.  Selective Cannabinoid 2 Receptor Stimulation Reduces Tubular Epithelial Cell Damage after Renal Ischemia-Reperfusion Injury.

Authors:  Jeffrey D Pressly; Suni M Mustafa; Ammaar H Adibi; Sahar Alghamdi; Pankaj Pandey; Kuldeep K Roy; Robert J Doerksen; Bob M Moore; Frank Park
Journal:  J Pharmacol Exp Ther       Date:  2017-11-29       Impact factor: 4.030

Review 2.  Spice-y Kidney Failure: A Case Report and Systematic Review of Acute Kidney Injury Attributable to the Use of Synthetic Cannabis.

Authors:  Ceyda Zarifi; Shuchi Vyas
Journal:  Perm J       Date:  2017

3.  Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity.

Authors:  Anna Pinson; Azure L Yarbrough; John M Bush; Christian V Cabanlong; Amal Shoeib; Bailey K Jackson; Saki Fukuda; Jyoti Gogoi; William E Fantegrossi; Keith McCain; Paul L Prather; Ryoichi Fujiwara; Anna Radominska-Pandya
Journal:  Pharmacol Biochem Behav       Date:  2020-05-13       Impact factor: 3.533

Review 4.  Systematic review of nephrotoxicity of drugs of abuse, 2005-2016.

Authors:  Kanaan Mansoor; Murad Kheetan; Saba Shahnawaz; Anna P Shapiro; Eva Patton-Tackett; Larry Dial; Gary Rankin; Prasanna Santhanam; Antonios H Tzamaloukas; Tibor Nadasdy; Joseph I Shapiro; Zeid J Khitan
Journal:  BMC Nephrol       Date:  2017-12-29       Impact factor: 2.388

5.  Disseminated Intravascular Coagulopathy Secondary to Unintentional Brodifacoum Poisoning via Synthetic Marijuana.

Authors:  Abigail Chan; Michael Adashek; Julian Kang; Adriana Medina
Journal:  J Hematol (Brossard)       Date:  2019-03-30

6.  Acute Kidney Injury Related to Intoxication From Synthetic Cannabis: Don't You Know That You're Toxic?

Authors:  Brett Curtis; Bishow Mahat; Michael Macklin; Jennifer Mihalo; Allie H Dakroub
Journal:  Cureus       Date:  2022-03-23

Review 7.  Acute Kidney Injury (AKI) in Young Synthetic Cannabinoids Abusers.

Authors:  Stefano D'Errico; Martina Zanon; Davide Radaelli; Monica Concato; Martina Padovano; Matteo Scopetti; Paola Frati; Vittorio Fineschi
Journal:  Biomedicines       Date:  2022-08-10

Review 8.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.